New Zealand patients first to receive new diabetes treatment
21 September 2016
People with type 2 diabetes in Auckland, Wellington, Christchurch, and Dunedin have been the first in the world to trial a new treatment.
The COMPLEMENT Study is using Metabolic Neuromodulation Therapy, in a one-off procedure, to change nerve signals to reduce blood sugar levels.
Almost half of people with type 2 diabetes can’t adequately control their blood sugar despite many medication options, and so they remain at risk of significant and costly complications. With type 2 diabetes reaching near-epidemic proportions new treatments are critically important.
The Study is being lead by expert endocrinologists and cardiologists including two Healthier Lives researchers: Dr Rinki Murphy and Associate Professor Jeremy Krebs.
Download the fact sheet, with contacts for enquiries:
Read the 2015 news article:
- Aucklanders needed for exclusive diabetes trial (Stuff website)
Healthier Lives diabetes research:
View our 2019-24 Research Strategy
He Pikinga Waiora Research Findings Brief
